# Cue Biopharma, Inc.: Form SCHEDULE 13D, filed Aug 21, 2026

- Company: [Cue Biopharma, Inc.](/companies/cue.md) (CIK 1645460)
- Form: SCHEDULE 13D
- Filed: 2026-08-21
- Accepted by EDGAR: Aug 21, 2026, 16:55 ET
- Period: not reported
- Accession: 0001725092-26-000015
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1645460/000172509226000015/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645460/000172509226000015/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645460/000172509226000015/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Aug 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001725092-26-000015. Last ingested by Listed: Nov 11, 2026, 02:48 ET. No prices; not investment advice.
